Literature DB >> 24445227

Relation between the expression of mitotic centromere-associated kinesin and the progression of squamous cell carcinoma of the tongue.

Cheng-Qin Wang1, Feng-Gang Xiang2, Yu-Jun Li3, Xiao-Ming Xing4, Ning Wang1, Jing-Hua Chi1, Wen-Juan Yu4.   

Abstract

OBJECTIVE: Mitotic centromere-associated kinesin (MCAK) is a microtubule depolymerase indispensable for microtubule binding during spindle formation. The purpose of this study was to investigate the association of MCAK expression with squamous cell carcinoma of the oral tongue (SCCOT). STUDY
DESIGN: Immunohistochemistry was used in 47 cases of SCCOT. Determination of proliferation and migratory capabilities was performed with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and Transwell chamber assay, respectively, on cells from the human tongue squamous cell carcinoma cell line Tca8113 that were transfected with MCAK small interfering RNA (siRNA).
RESULTS: MCAK expression level in oral tongue cancer tissue is significantly higher (P < .01) than that of corresponding normal tissue. In addition, high expression of MCAK is significantly associated with lymph node metastasis (P < .05) and tumor staging (P < .01). Moreover, gene silencing of MCAK suppresses proliferation and migration of Tca8113 cells (P < .05; P < .01).
CONCLUSIONS: The expression of MCAK may be associated with the progression of SCCOT. Crown
Copyright © 2014. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24445227     DOI: 10.1016/j.oooo.2013.11.488

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  4 in total

1.  Identification of core biomarkers associated with pathogenesis and prognostic outcomes of laryngeal squamous-cell cancer using bioinformatics analysis.

Authors:  Wei Chen; Lianming Liao; Haichun Lai; Xuehan Yi; Desheng Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-02-17       Impact factor: 2.503

2.  MicroRNA-2053 involves in the progression of esophageal cancer by targeting KIF3C.

Authors:  Wenjian Yao; Xiangbo Jia; Lei Xu; Saisai Li; Li Wei
Journal:  Cell Cycle       Date:  2021-05-31       Impact factor: 5.173

3.  CBX6 Promotes HCC Metastasis Via Transcription Factors Snail/Zeb1-Mediated EMT Mechanism.

Authors:  Jiamu Wang; Hui He; Qiucheng Jiang; Yu Wang; Shuzhao Jia
Journal:  Onco Targets Ther       Date:  2020-12-04       Impact factor: 4.147

4.  Suppression of KIF3A inhibits triple negative breast cancer growth and metastasis by repressing Rb-E2F signaling and epithelial-mesenchymal transition.

Authors:  Weilin Wang; Runze Zhang; Xiao Wang; Ning Wang; Jing Zhao; Zhimin Wei; Fenggang Xiang; Chengqin Wang
Journal:  Cancer Sci       Date:  2020-02-28       Impact factor: 6.716

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.